Abstract
Unlimited proliferation in immortalized cells is believed to be highly dependent on the activity of telomerase, a ribonucleoprotein that synthesizes telomeric repeats onto chromosome ends. Using a polymerase chain reaction-based telomeric repeat amplification protocol (TRAP) assay, we analysed telomerase activity in 99 benign and 45 malignant brain tumours. The TRAP assay results were quantitated by normalizing the telomerase activity of each specimen to that of human glioma cell line T98G to obtain the relative telomerase activity. Telomerase activity was also assessed visually from the autoradiograms as being positive or negative. One hundred and sixteen tumours with negative telomerase activity had null relative telomerase activity, whereas 28 tumours with positive telomerase activity had relative telomerase activities of 12-84.3% (mean 0% vs 36.1 +/- 19.3%, P < 0.0001). Thus, quantification of telomerase activity confirmed the results of the visual evaluation of telomerase activity on autoradiograms. Based on the assessment, malignant brain tumours had a higher positive rate of telomerase activity than benign tumours (57.8% vs 2.0%, P < 0.001). These data indicate that positive telomerase activity is strongly associated with malignant brain tumours and is rather rare in benign tumours, such as neurinomas or meningiomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sano, T., Asai, A., Mishima, K. et al. Telomerase activity in 144 brain tumours. Br J Cancer 77, 1633–1637 (1998). https://doi.org/10.1038/bjc.1998.267
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.267
This article is cited by
-
RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells
Cytotechnology (2016)
-
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Virchows Archiv (2014)
-
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
Acta Neuropathologica (2013)
-
Src homology domain-containing phosphatase 2 suppresses cellular senescence in glioblastoma
British Journal of Cancer (2011)
-
hTERT immunopositivity patterns in the normal brain and in astrocytic tumors
Acta Neuropathologica (2006)